Peptide Therapeutics Market Size Worth USD 313.33 Billion by 2034 | CAGR: 10.5%

The peptide therapeutics market size is expected to reach USD 313.33 Billion by 2034, according to a new study by Polaris Market Research. The report “Peptide Therapeutics Market Size, Share, Trends, & Industry Analysis Report By Type (Generic and Innovative), By Type of Manufacturers, By Route of Administration, By Synthesis Technology, By Application, and By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The peptide therapeutics market is evolving as pharmaceutical and biotechnology companies develop advanced formulations with improved stability, bioavailability, and delivery mechanisms. Growing improvements in peptide synthesis technologies and solid-phase manufacturing processes, lowered the production costs and expanded formulation options.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/peptide-therapeutics-market/request-for-sample

Additionally, regulatory agencies are facilitating the approval of novel peptide drugs through supportive frameworks, further accelerating the market growth. The growing portfolio of peptide-based products in the clinical pipeline and increasing commercialization activity are boosting market expansion across oncology, metabolic disorders, infectious diseases, and rare therapeutic areas.

Peptide Therapeutics Market Report Highlights

• In terms of type, the innovative peptide therapeutics segment emerged as the market leader in revenue share during 2024 due its superior pharmacological properties and proven effectiveness in treating challenging conditions across oncology, metabolic disorders, and rare diseases.
• In terms of type of manufacturers, the outsourced manufacturing segment is gaining momentum as biotech firms and specialty developers increasingly partner with CDMOs.
• Based on route of administration, the parenteral route segment secured the largest revenue share in 2024, maintaining its position as the preferred delivery method for peptide-based treatments.
• North America captured a dominant 60.21% share of the global peptide therapeutics market in 2024 due to the region's cutting-edge healthcare infrastructure, robust research capabilities, and comprehensive medical reimbursement frameworks.
• The Asia Pacific peptide therapeutics market is poised to register the fastest CAGR during the forecast period due to increasing governmental support for biopharmaceutical innovation, with investments in domestic drug development.
• A few global key market players include Advanced Accelerator Applications SA, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Bracco Imaging S.p.A., Cardinal Health, Inc., Curium Pharma, Eckert & Ziegler SE, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., GlaxoSmithKline plc (GSK plc), Jubilant Radiopharma Limited, Lantheus Holdings, Inc., Eli Lilly and Company, and Mallinckrodt plc.

Polaris Market Research has segmented the market report on the basis of type, type of manufacturers, route of administration, synthesis technology, application, and region:

By Type Outlook (Revenue, USD Billion, 2020–2034)

• Generic
• Innovative

By Type of Manufacturers Outlook (Revenue, USD Billion, 2020–2034)

• In-house
• Outsourced

By Route of Administration Outlook (Revenue, USD Billion, 2020–2034)

• Parenteral Route
• Oral Route
• Pulmonary
• Mucosal
• Others

By Synthesis Technology Outlook (Revenue, USD Billion, 2020–2034)

• Solid Phase Peptide Synthesis (SPPS)
• Recombinant DNA Technology
• Hybrid Technology
• Liquid-Phase Peptide Synthesis (LPPS)
• Others

By Application Outlook (Revenue, USD Billion, 2020–2034)

• Cancer
• Metabolic Disorders
• Cardiovascular Disorders
• Respiratory Disorders
• Gastrointestinal Disorders
• Infectious Diseases
• Pain
• Dermatological Disorders
• Neurological Disorders
• Renal Disorders
• Others

By Regional Outlook (Revenue, USD Billion, 2020–2034)

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America